<qa>  What is the purpose of this study?The purpose of this study is to compare the Time To Disease Progression TTDP between those patients with unresectable, locally recurrent or metastatic breast cancer who are treated with concomitant Docetaxel plus Gemcitabine to those patients treated with sequential therapy of Docetaxel followed by Gemcitabine. 